A carregar...
ATIM-25. NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA
BACKGROUND: The use of anti-PD-1 therapy, pembrolizumab, has shown minimal therapeutic effect as an adjuvant treatment in glioblastoma, but its efficacy as a neoadjuvant in recurrent glioblastoma setting has yet to be established. METHODS: The Ivy Foundation Early Phase Clinical Trials’ Consortium c...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216135/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.020 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|